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Abstract
Matrix metalloproteinase-9 (MMP-9), or gelatinase B, has been hypothesized to be 
involved in the progression of atherosclerosis. In the arterial wall, accumulated mac-
rophages secrete considerable amounts of MMP-9 but its pathophysiological func-
tions in atherosclerosis have not been fully elucidated. To examine the hypothesis 
that macrophage-derived MMP-9 may affect atherosclerosis, we created MMP-9 
transgenic (Tg) rabbits to overexpress the rabbit MMP-9 gene under the control of 
the scavenger receptor A enhancer/promoter and examined their susceptibility to 
cholesterol diet-induced atherosclerosis. Tg rabbits along with non-Tg rabbits were 
fed a cholesterol diet for 16 and 28 weeks, and their aortic and coronary atheroscle-
rosis was compared. Gross aortic lesion areas were significantly increased in female 
Tg rabbits at 28 weeks; however, pathological examination revealed that all the le-
sions of Tg rabbits fed a cholesterol diet for either 16 or 28 weeks were characterized 
by increased monocyte/macrophage accumulation and prominent lipid core forma-
tion compared with those of non-Tg rabbits. Macrophages isolated from Tg rabbits 
exhibited higher infiltrative activity towards a chemoattractant, MCP-1 in vitro and 
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1  | INTRODUC TION
Matrix metalloproteinases (MMPs), first described in 1962,1 are a 
family of zinc-dependent endopeptidases with more than 23 kinds 
reported in humans.2 MMPs play crucial roles in several physio-
logical processes, including tissue remodelling, immune functions, 
reproduction and development, but are also involved in many patho-
logical processes, such as tumour invasion, autoimmune diseases, 
neurodegenerative disorders and cardiovascular diseases.3-5 MMPs 
are roughly divided into two major types according to their molec-
ular properties: membrane-anchored and secreted. Furthermore, 
based on the hydrolysis substrates, secreted-type MMPs can be fur-
ther classified into collagenases, gelatinases, stromelysins and matri-
lysins.5-7 In addition to their enzymatic activities, MMPs also exhibit 
a number of other pathophysiological functions independent upon 
their ECM hydrolysis.8-10
The gelatinases, including MMP-2 (72-kD) and MMP-9 (92-kD), 
are different from other MMPs due to a collagen-binding domain 
within the catalytic domain that is involved in the binding of col-
lagenous substrates, elastin and thrombospondins.11 MMP-9, also 
called gelatinase B, was first discovered as an enzyme involved in 
extracellular matrix (ECM) remodelling by degradation of denatured 
collagens (gelatins).12 In the arterial walls, MMP-9 is synthesized and 
secreted by endothelial cells, smooth muscle cells as well as macro-
phages and is involved in the regulation of cell survival, migration, 
inflammation and angiogenesis.2,13 Increased MMP-9 activity is as-
sociated with several diseases such as asthma,14 systemic lupus ery-
thematosus,15 abdominal aortic aneurysms,16 plaque rupture,17 left 
ventricular hypertrophy18 and stroke.19
Accumulation of monocytes and macrophage-derived foam cells 
in the intima of large arteries is a hallmark of human and experimen-
tal animal atherosclerosis.20 Macrophages and macrophage-derived 
foam cells in the arterial wall secrete substantial amounts of MMP-9, 
in concert with other MMPs, which have been considered to partici-
pate in the pathogenesis of atherosclerosis and plaque rupture.17,21,22 
However, it is not clear whether macrophage-derived MMP-9 is 
directly involved in the initiation or progression or both of athero-
sclerosis although MMP-9 was detected in the lesions of human 
atherosclerosis.23,24 Functional polymorphism in the regulatory re-
gion of MMP-9 has been found to be associated with the severity of 
coronary atherosclerosis,25 whereas high levels of plasma MMP-9 
protein concentrations are closely correlated with acute coronary 
syndrome.26,27 However, conflicting results have been reported in 
terms of MMP-9 function in the pathogenesis of atherosclerosis 
using apoE knockout (KO) mice. In one report, MMP-9 deficiency 
protected against cholesterol diet-induced atherosclerosis,28 but in 
another, MMP-9 inactivation increased the atherosclerotic plaque 
growth and progression.29 In addition, a report indicated that over-
expressing human MMP-9 in macrophages increased collagen con-
tent in lesions but showed no effects on atherosclerotic lesions in 
apoE KO mice.30 Recently, we performed an RNAseq analysis of the 
aortic lesions of both cholesterol-fed and WHHL rabbits and showed 
that MMP-9 along with MMP-1 and MMP-12 was predominately 
up-regulated compared with aortas of normal wild-type rabbits.31 As 
MMP-9 is able to degrade several other ECMs in the arterial wall, we 
hypothesized that elevation of MMP-9 expression may participate in 
or mediate atherosclerotic lesion formation. To test this hypothesis, 
we generated transgenic (Tg) rabbits overexpressing rabbit MMP-9 
gene specifically in the macrophage lineage and foam cells of athero-
sclerotic lesions. The rationale of using rabbits for this undertaking is 
twofold. First, compared with wild-type murine models, rabbits are 
more sensitive to a cholesterol diet and develop atherosclerosis rap-
idly. Therefore, it is possible to generate different types of athero-
sclerotic lesions in cholesterol-fed rabbits. Second, atherosclerotic 
lesions of cholesterol-fed rabbits are rich in macrophage-derived 
foam cells, which facilitates the analysis of macrophage functions in 
the arterial wall.32 To the best of our knowledge, this is the first re-
port to demonstrate that overexpression of MMP-9 in macrophages 
is not only involved in the progression of atherosclerosis but also 
increases vascular calcification.
2  | MATERIAL S AND METHODS
2.1 | Generation and characterization of Tg rabbits
Tg rabbits were generated by the methods established in our labora-
tory as reported previously.33,34 The DNA construct used for micro-
injection was composed of rabbit MMP-9 cDNA under the control of 
the human scavenger receptor enhancer/promoter along with four 
augmented capability of hydrolysing extracellular matrix in granulomatous tissue. 
Surprisingly, the lesions of Tg rabbits showed more advanced lesions with remarkable 
calcification in both aortas and coronary arteries. In conclusion, macrophage-derived 
MMP-9 facilitates the infiltration of monocyte/macrophages into the lesions thereby 
enhancing the progression of atherosclerosis. Increased accumulation of lesional 
macrophages may promote vascular calcification.
K E Y W O R D S
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copies of the chicken β globin insulator (Figure 1A), which prevents 
the position effect of transgene insulators.35,36 In total, 1032 em-
bryos were injected, and 879 embryos were implanted into 40 recip-
ient female rabbits. Ten recipients gave birth to 26 pups, and among 
them, 2 pups were found to carry the transgenes by Southern blot-
ting (Figure 1B). Because mRNA expression levels of MMP-9 ana-
lysed by Northern blots were similar in both founders, Tg founder F1 
rabbit was mated with wild-type rabbits to produce following prog-
eny. In this study, rabbits at the age of 4 months were used unless 
otherwise specified. All rabbits were fed either with a chow diet or 
cholesterol-rich diet containing 0.5% cholesterol and 3% soybean oil 
(see below).37 The rabbits were allowed access to the diet and water 
ad libitum. Plasma levels of total cholesterol (TC), triglycerides (TG) 
and HDL-cholesterol (HDL-C) were analysed weekly using the meth-
ods described previously.38 All animal experiments were performed 
with the approval of the Animal Care Committee of the Universities 
of Yamanashi and Saga and conformed to the Guide for the Care and 
Use of Laboratory Animals published by the US National Institutes 
of Health.
2.2 | Analysis of MMP-9 expression
To examine the tissue expression of MMP-9 in Tg and non-Tg rabbits, 
Northern blotting was performed as described previously.39 In brief, 
total RNA was isolated from bone marrow, lung, spleen, liver, aorta, 
heart, kidney, adrenal, pancreas, and both alveolar and peritoneal 
macrophages (see below) using TRIzol reagent (Life Technologies, 
Inc) and 10 μg of RNA was denatured in the presence of dimethyl 
sulfoxide and glyoxal was subjected to electrophoresis in a 1.2% 
formaldehyde agarose gel, and then transferred to a Nitran nylon 
membrane and then treated with UV light in the UV crosslinker. The 
membrane was hybridized with the 32P-labelled a rabbit MMP-9 
cDNA probe synthesized with a Prime-It II random primer labelling 
kit (Stratagene). The blot was rehybridized with a 32P-labelled human 
β-actin probe (Clontech Laboratories) to confirm that equal amounts 
of RNA were loaded in each lane. To evaluate MMP-9 protein ex-
pression and enzymatic activity, we collected elicited peritoneal 
macrophages from the peritoneal cavity 4 days after injection of 
4% Brewer's thioglycollate broth, as described previously.40 In brief, 
rabbits were anaesthetized by intramuscular injection of ketamine 
(25 mg/kg BW) + medetomidine hydrochloride (0.5 mg/kg BW) and 
restrained with ventral side up. Thioglycollate broth loaded in 50-mL 
syringes was injected into the peritoneal cavity. 4 days later, rab-
bits were euthanized by injection of sodium pentobarbital solution 
(100 mg/kg BW) through an ear vein. Abdominal cavity was cut open 
along the middle line and washed three times using 100 mL of phos-
phate-buffered saline (pH 7.4) with heparin (10 U/L). After centrifu-
gation, peritoneal macrophages (10 × 106) from either Tg or non-Tg 
rabbits (n = 5 for each group) were incubated in serum-free 1640 me-
dium with or without phorbol 12-myristate 13-acetate (Sigma-Aldrich 
Com) (50 ng/mL) for 48 hours, and the conditioned media were then 
collected for Western blotting and gelatin zymographic analysis.32 
The same aliquots of the conditioned media from each group were 
fractionated by electrophoresis on 10% SDS-polyacrylamide gels, 
transferred onto a nitrocellulose membrane, then incubated with 
monoclonal antibody (mAb) (Table S1) against human MMP-9, which 
cross-reacted with rabbit MMP-9. To evaluate gelatinase activity, we 
first performed gelatin gel zymographic analysis using the method 
reported previously.32 Briefly, a piece of fresh aortic arch was ho-
mogenized in ice-cold RIPA. 20 μg proteins were separated by elec-
trophoresis through 8% SDS-polyacrylamide gels containing gelatin 
(1 mg/mL) (Wako Pure Chemical Industries Ltd., Osaka, Japan) under 
non-denaturing and non-reducing conditions. After washing in 2.5% 
Triton X-100 (Sigma-Aldrich) to remove SDS, the gels were incubated 
in buffer solution (50 mmol/L Tris-HCl, pH = 7.5, 10 mmol/L CaCl2, 
1 μmol/L ZnCl2, 0.2 mmol/L NaN3 and 0.05% BRIJ-35) at 37°C for 
36 hours. After that, the gels were stained by Coomassie Brilliant 
Blue (Wako) till the bands were visualized. Areas of enzymatic activ-
ity showed as clear bands over the mazarine background. Gels were 
scanned, and the density of digested bands was quantified with 
ImageJ software (National Institutes of Health). To measure the en-
zymatic activity of gelatinases in the aortic tissue directly, we exam-
ined gelatin activity of aortic arch homogenate (n = 4 for each group) 
with an EnzChek Gelatinase kit (Molecular Probes, Eugene, Oregon). 
100 μg of crude protein of each sample was incubated with quenched 
fluorescein-conjugated gelatin at 37°C in darkness. Active enzymes 
cleave the fluorescent-labelled gelatin and the rate of proteolysis 
was expressed by fluorescence intensity. To verify the gelatinase ac-
tivity specificity, aortic arch homogenate was incubated with MMP-
2/9 inhibitor (10 μmol/L) (SB-3CT, Santa Cruz Biotechnology, Inc) for 
1 hour at 37°C before mixed with quenched fluorescein-conjugated 
gelatin. Fluorescence was measured at multiple time-points during 
reaction using a SpectraMax Microplate Reader (Molecular Devices) 
(absorption 490 nm/emission 515 nm). We also performed in situ ge-
latinolytic activity using frozen sections of aortic arch as previously 
reported. 8-µm-thick cryosections were air-dried for 10 minutes. 
After that, sections were washed with PBS to remove traces of OCT. 
Quenched fluorescein-conjugated gelatin (Molecular Probes) was 
used as the substrate. The gelatin (20 µg/mL), which was dissolved 
in reaction buffer with 10% low gelling agarose (Sigma-Aldrich), was 
dropped on the top of sections and incubated with reaction buffer 
in a dark humidity chamber at 37°C for 6 hours. 5 mmol/L EDTA in 
reaction buffer was used to block gelatinase activity. The sections 
were then rinsed with PBS and stained with DAPI for staining nuclei. 
Slides were then mounted with a cover glass using an aqueous agent.
2.3 | Experimental design
Tg rabbits along with sex- and age-matched non-Tg littermates were 
used for the following experiment. In the first experiment, rabbits 
(male group: n = 6 for non-Tg and n = 7 for Tg, female group: n = 3 
for non-Tg and n = 7 for Tg) were fed a diet containing 0.5% choles-
terol and 3% soybean oil for 16 weeks. The lesions of atherosclerosis 
formed in these rabbits were mainly those of so-called early-stage 
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lesions (fatty streaks), and thus, it was amenable to evaluate the 
effects of increased MMP-9 expression on the initiation of ath-
erosclerosis. In the second experiment, rabbits (male group: n = 10 
for non-Tg and n = 12 for Tg, female group: n = 10 for non-Tg and 
n = 16 for Tg) were fed the same cholesterol-rich diet for 28 weeks. 
Long-duration hypercholesterolaemia in the second experiment in 
comparison with the first experiment was expected to induce more 
advanced atherosclerotic lesions, such as fibrous plaques and com-
plicated plaques, in these rabbits.41,42 Therefore, we were able to 
address the influence of MMP-9 expression on the progression of 
atherosclerosis.
2.4 | Analysis of aortic atherosclerosis
At the end of cholesterol diet feeding, all rabbits were euthanized by 
injection of sodium pentobarbital solution (100 mg/kg BW) through 
an ear vein. The aortas were en face stained by Sudan IV solution 
for quantitative analysis of the gross atherosclerotic lesion area as 
described previously.43 For microscopic quantification of the lesion 
area, each segment of the aorta arch from all rabbits was cut into 
cross sections as reported previously.37,44 Then, all specimens were 
embedded in paraffin and sections (3 μm) were stained with haema-
toxylin and eosin (HE) and elastica van Gieson (EVG). For further mi-
croscopic evaluation of cellular components and MMP-9 expression 
in the lesions, serial paraffin sections of the aorta arch were immu-
nohistochemically stained with mAbs against rabbit macrophages 
(RAM11), α-smooth muscle actin (HHF35), MMP-9 and caspase-3 
(Table S1). The following antigen retrieval method was used. Citrate 
buffer was prepared by mixing 0.1 mol/L citric acid with 0.1 mol/L 
sodium citrate hydrate solution as 1:4. Then, paraffin-embedded 
section slides were immersed in the citrate buffer and autoclaved 
at 120°C for 10 minutes. After that, slides were washed with PBS 
once and blocked with 10% goat serum at room temperature for 
30 minutes. Abs were diluted in 10% goat serum, and slides were 
incubated with each first Ab at 4°C for overnight and followed by 
F I G U R E  1   Transgenic construct for generation of transgenic rabbits. The DNA construct used for microinjection was composed of 
rabbit MMP-9 cDNA under the control of a human scavenger receptor A enhancer/promoter region (5 kb) along with four copies of the 
chicken β globin insulator (A). Two Tg founders (designated as F1 and F2) were identified by Southern blot analysis using a rabbit MMP-9 
cDNA probe (B). Northern blotting analysis revealed that endogenous MMP-9 expression was mainly in the bone marrow of non-Tg rabbits, 
whereas Tg MMP-9 was expressed in isolated macrophages, bone marrow and lungs. GAPDH was used as an internal control (C). Peritoneal 
macrophages were isolated from both Tg and non-Tg rabbits (3-mon), and incubated in serum-free medium for 48 h with or without PMA. 
Conditioned media were collected and analysed for MMP-9 protein and enzymatic activity by Western blotting and zymographic analysis. 
Each lane represents a sample from an individual animal and n = 3 for each group (D)
     |  4265CHEN Et al.
peroxidase-conjugated goat-antimouse IgG (Histofine Sab-Po(M), 
Nichirei Bioscience, Inc) for 1 hour at room temperature. Amino-9-
ethylcarbazole (AEC) (Nichirei Bioscience) was used as a substrate 
for visualizing the antigen signals and nuclei were stained with hae-
matoxylin. To evaluate Ab specificity, the slides were incubated with 
mouse non-specific IgG or PBS to replace the first Ab (Figures S11 
and S12). Aortic lesions were histologically classified into early-stage 
lesions (type II lesions: either fatty streaks with foam cells > 60% of 
the lesions or fibrotic lesions mainly composed by SMCs and ECM 
with foam cells < 50%) or advanced lesions (type IV atheroma or V 
fibroatheroma containing typical lipid or necrotic cores with calci-
fication) according to the AHA classification.45 The lengths of each 
lesion on each section were measured and quantified as reported 
previously.46 In addition, the severity of the aortic calcification 
was evaluated by measuring the calcification area on each section 
of the aortic arch based on von Kossa staining. All section images 
for microscopic quantification were taken with an Olympus BX51 
light microscope equipped with a DP70 digital camera (Olympus) 
and quantified with Lumina Vision V2.04 image analysis software 
(Mitani Co.). For this undertaking, we defined a colour pixel thresh-
old of immunostaining intensity to detect the AEC-stained red col-
our by selecting areas first, and then, we used the same threshold to 
measure colour intensity in each specimen. For analysis of Mϕ, SMC 
and calcification in cellular distribution, we measured and showed 
the real positive area. Atherosclerotic quantification was performed 
by two independent observers blindly. Aortic lesions were also col-
lected and homogenized for gelatinase activity and Western blotting 
analysis using mAbs against MMPs and tissue inhibitors of matrix 
metalloproteinase (TIMPs) shown inTable S1.32 In brief, aortic arch 
was homogenized in ice-cold RIPA buffer (Thermo Fisher Scientific) 
supplemented with a proteinase inhibitor cocktail (1% v/v) (Sigma-
Aldrich). After centrifugation, the supernatant was collected for 
measuring protein content by a Bio-Rad protein assay kit. The super-
natant was aliquoted for performing Western blotting, zymography 
and enzymatic assay. For Western blotting analysis, equal amounts 
of crude protein (30 μg) were fractionated by electrophoresis on 
10% SDS-ployacrylamide gels under reducing condition. After that, 
the proteins were transferred to Bio-Rad's 0.2 μm pore-size nitrocel-
lulose membranes and these membranes were incubated with each 
Ab (Table S1) at 4°C overnight, and then washed three times with 
PBST (0.1% Tween 20 in 1X PBS) and reacted with horseradish per-
oxidase-conjugated secondary Abs, followed by enhanced chemilu-
minescence detection.
2.5 | Analysis of coronary lesions
To assess coronary atherosclerosis, all hearts of both male and fe-
male rabbits of the second experiment were cut into five blocks 
and the block-I, which contains the main trunk of the left coronary 
artery, was used for coronary lesion analysis. The whole protocol 
for heart sections was described in details elsewhere42 and also can 
be obtained from the Appendix A. Supplementary data published 
through the following website: http://www.scien cedir ect.com/scien 
ce/artic le/pii/S0163 72581 4001855). The blocks were cut into 4 se-
rial sections (3 μm thick) at 50 μm intervals, and in total, 4 cuts were 
conducted. For 4 sections collected from each cut were stained for 
HE, EVG, and von Kossa or immunohistochemically stained with 
mAb (RAM11) against macrophages. The lesion size was quantified 
by EVG-stained specimens and expressed as stenosis % (lesion area/ 
coronary lumen area). Calcification and Mϕ areas were quantified as 
aortic lesion analysis described above and expressed as mm2.
2.6 | TUNEL staining
To evaluate the presence of cellular apoptosis in the lesions, se-
rial sections of paraffin-embedded aortas were either immuno-
histochemically stained by Abs against macrophage, caspase-3 
or by TUNEL (TdT-mediated dUTP nick end labelling) method 
using ApopTag peroxidase in situ apoptosis detection kits (S7100, 
Millipore). For TUNEL staining, all the procedures followed the 
manufacturer's instruction. Briefly, sections of the aortic arch were 
deparaffinized and rehydrated through xylene and graded ethanol 
to distilled water. Then, specimens were treated in 3.0% hydro-
gen peroxide in PBS solution for 5 minutes at room temperature 
for quenching endogenous peroxidase. Terminal deoxynucleotidyl 
transferase (TdT) with digoxigenin labelled deoxyuridine triphos-
phate was added and incubated in a humidified chamber at 37°C for 
30 minutes and then washed with PBS buffer. After that, specimens 
were incubated with peroxidase-conjugated anti-digoxigenin Ab in a 
humidified chamber for 30 minutes at room temperature and then 
washed 4 times in PBS. After that, AEC (Nichirei Bioscience) was 
added for visualizing the nucleotides, and nuclei were stained with 
haematoxylin. The negative control was conducted by using PBS to 
replace TdT (Figure S13).
2.7 | Tartrate-resistant acid phosphatase 
(TRAP) staining
Sections of aorta arch were deparaffinized and rehydrated through 
graded ethanol to distilled water. The slides were then incubated 
with TRAP staining solution which contained 0.1 mg/mL naph-
thol AS-MX (Sigma-Aldrich) and 0.08 mg/mL fast red violet LB salt 
(Sigma-Aldrich) in the presence of 8 mmol/L sodium tartrate and 
30 mmol/L sodium acetate (pH 5.0) at 37°C for 2 hours. After rinsing 
in distilled water, the slides were mounted with aqueous mounting 
medium.
2.8 | Chemotaxis analysis and carrageenan-
induced granuloma
To examine the effects of MMP-9 enzymatic activity on macrophage 
migration and matrix digestion, we performed chemotaxis analysis 
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and granuloma assays. Chemotaxis assays for alveolar macrophages 
isolated from Tg and non-Tg rabbits (n = 4 for each group) were per-
formed using Biocoat cell culture inserts coated with laminin (Becton 
Dickinson Labware, Bedford, MA). The lower compartments were 
loaded with the same medium containing human recombinant 
monocyte chemoattractant protein-1 (MCP-1) (Pepro Tech EC) at 
10 ng/mL. After 48 hours of incubation (37°C, 5% CO2), the number 
of macrophages that penetrated the membranes was counted in 10 
high-power fields randomly from each well.
We generated a carrageenan-induced granuloma model that 
mimics the condition of macrophages and foam cells accumulated 
in atherosclerosis lesions as previously reported,40 to compare the 
infiltrative and degradative functions of macrophages of Tg rabbits 
with those of non-Tg rabbits. To investigate the histological features 
of the granuloma, the granulomatous tissues after subcutaneous in-
jection of carrageenan solution (Sigma-Aldrich) for 14 days were iso-
lated and fixed in 10% buffered formalin, embedded in paraffin, and 
then cut into sections (3 μm). To analyse the collagen fibre content 
in the granuloma, the sections were stained with Masson trichrome 
staining. The total area of collagen staining was calculated using the 
image analysis system as above described.
2.9 | Statistical analysis
Statistical analysis was performed using SPSS 16.0 software. All data 
are expressed as mean ± SEM. Statistical analysis was performed 
for parametric data by Student's t test and for non-parametric data 
(calcification study) by the Mann-Whitney U test. In all cases, signifi-
cance was set as a P-value <.05.
3  | RESULTS
3.1 | Generation of Tg rabbits
We generated 2 Tg founder rabbits as shown by Southern blot-
ting analysis (Figure 1B). One founder rabbit was bred to provide 
F1 progeny for the current study. Tg rabbits did not exhibit any vis-
ible abnormalities in the whole-body appearance and histological 
examinations did not reveal any pathological changes in heart, lung, 
spleen, adrenal and liver. Peripheral blood white cells in Tg rabbits 
were not different from those of non-Tg rabbits (data not shown). 
Northern blotting analysis revealed that Tg rabbits expressed promi-
nent MMP-9 mRNA in peritoneal and alveolar macrophages and 
macrophage-rich organs (lung and bone marrow), whereas in non-Tg 
rabbits, endogenous MMP-9 mRNA expression was extremely low 
and only detected in the bone marrow, presumably in bone marrow 
macrophages (Figure 1C). To analyse MMP-9 proteins and enzymatic 
activity, we isolated elicited macrophages from the peritoneal cavity 
of rabbits. On Western blotting analysis of the conditioned media, 
the peritoneal macrophages from Tg rabbits secreted approximately 
10-fold more (without PMA treatment) and fourfold more (after 
PMA treatment) MMP-9 protein than control macrophages, as calcu-
lated by OD values (Figure 1D). Gelatin zymography demonstrated 
that MMP-9 proteins secreted by macrophages are enzymatically 
active (Figure 1D).
3.2 | Effects of MMP-9 on the initiation of 
atherosclerosis
We first examined whether MMP-9 overexpression affected the 
early-stage lesion formation of atherosclerosis in rabbits fed a cho-
lesterol diet for 16 weeks. As shown in Figure S1, both male and fe-
male Tg and non-Tg rabbits developed similar hypercholesterolaemia 
throughout the experiment. The aortic lesions were mainly found in 
the aortic arch, and the gross lesion area was not significantly differ-
ent between Tg and non-Tg rabbits of both male and female (Figure 
S2). Histological examinations revealed that the lesions of aortic 
atherosclerosis in Tg and non-Tg rabbits were predominantly com-
posed of type II lesions (fatty streaks), which were characterized by 
foam cell accumulation intermingled with small numbers of smooth 
muscle cells and ECM; however, the number of lesional macrophages 
was significantly increased by 2.8-fold in male (Figure 2) and 1.3-
fold in female Tg rabbits (Figure S3). In these areas, MMP-9 immuno-
reactive proteins were co-localized with macrophages in Tg rabbits, 
whereas MMP-9 was barely stained in the lesions of non-Tg rabbits 
(Figure 2 and Figure S3).
3.3 | Effects of MMP-9 on the progression of 
atherosclerosis
In the second experiment, we fed rabbits with a cholesterol diet for 
28 weeks to examine whether increased MMP-9 expression influ-
enced the advanced lesion formation. Compared with the experi-
ment 1 in which the lesions were smaller in size and mainly consisted 
of the fatty streaks, the lesions of the experiment 2 were more 
extensive and predominately by advanced lesions, such as fibrous 
plaques and atheroma (types IV-V lesions).40 The total cholesterol 
levels of Tg and non-Tg rabbits were essentially similar (Figure S4) 
but sudanophilic areas (gross lesions) and total microscopic lesions 
of the aortic arch were significantly increased in female Tg rabbits 
compared with non-Tg littermates, even though no significant dif-
ference in male Tg rabbits compared with non-Tg controls (Figures 
S5, S6 and Figure 3). Regardless of this gender difference in lesion 
size, microscopic examinations showed that the advanced lesions 
(types IV-V lesions) were increased in both male and female Tg rab-
bits: threefold greater in male and 2.8-fold larger in female Tg rabbits 
than those in non-Tg rabbits (Figure 3 and Figure S6). In contrast to 
the fatty streaks which are enriched in macrophages and foam cells, 
advanced lesions were characterized by necrotic or lipid cores cov-
ered by a layer of fibrotic cap and were frequently associated with 
marked calcium deposition or calcification (Figure 3). In addition, 
macrophage staining area was significantly increased by 1.9-fold in 
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male and 1.6-fold in female Tg rabbits compared with non-Tg rabbits 
whereas SMC components in the lesions were unchanged between 
Tg and non-Tg rabbits (Figure 3 and Figure S6).
One of the striking features of advanced lesions observed in Tg 
rabbits was the prominent vascular calcification (Figure 4). Although 
calcifications are not specific in the lesions of atherosclerosis in 
cholesterol-fed Tg rabbits, 98% of Tg rabbits (26/27) showed se-
vere calcified lesions associated with atherosclerosis, whereas only 
40% (8/20) of non-Tg rabbits had calcified lesions as observed under 
light microscopy using HE and von Kossa stained specimens. In ad-
dition to the higher prevalence of vascular calcification in Tg rabbits, 
average calcified areas along with calcified length on the sections 
stained by von Kossa staining in the aortic lesions of Tg rabbits were 
much larger than those in non-Tg rabbits: 5.6-fold greater in males 
and 12.9-fold greater in females (Figure 4). Calcification was not only 
found in the deep areas of the lesions such as lipid cores (Figure 4) but 
also observed in the fatty streaks where many macrophage-derived 
foam cells (presumably those of apoptotic macrophages as shown 
below) were present (Figure 5A). In some areas, calcified lesions of 
Tg rabbits showed apparent ‘unstable’ vulnerable features such as 
large lipid core with a thin fibrotic cap accompanied by macrophage 
accumulation in the shoulders (Figure 5B). In macrophage-rich re-
gions, we could also observe many so-called microcalcification-gen-
erating matrix vesicles (Figure 5C). Many lesional macrophages 
associated with calcification were assumptively apoptotic because 
they could be stained by both TUNEL and caspase-3 staining (Figure 
S7). Interestingly, marked calcification was also found in coronary 
arteries: 21.6-fold increase of calcification areas in male Tg rabbits 
(Figure 6) and 12.9-fold increase in female Tg rabbits (Figure S8). In 
these calcified areas, marked macrophage accumulation was often 
observed: 8.1-fold increase in male Tg rabbits and 2.5-fold increase 
in female Tg rabbits compared with non-Tg rabbits. Coronary ste-
nosis was increased in male Tg rabbits even though not significantly 
different (ns).
In addition to the severe advanced lesions associated with prom-
inent calcification in Tg rabbits described above, macrophages fre-
quently expanded the deep parts of the tunica media or even the 
adventitial layers (Figure S9).
3.4 | Expression of MMPs and their endogenous 
inhibitors in lesions
To examine MMP-9 expression along with other MMPs and TIMPs 
in the lesions, we further quantified the content of MMP-2, MMP-
9, MMP-12 and TIMP-1 and TIMP-2. In compatible with the finding 
shown by immunohistochemical staining (Figure 2 and Figure S3), 
increased expression of MMP-9 proteins were further confirmed 
F I G U R E  2   Comparison of histological features of early-stage atherosclerotic lesions. Male Tg and non-Tg rabbits were fed a cholesterol 
diet for 16 weeks, and the aortic lesions were then quantified microscopically. Representative micrographs of the aortic arch lesions are 
shown on the top panel. Serial paraffin sections of the aortic arch were stained with haematoxylin and eosin (HE), or immunohistochemically 
stained with monoclonal antibodies (mAbs) against either macrophages (Mϕ), or α-smooth muscle actin for smooth muscle cells (SMC) or 
MMP-9. Intimal lesions on EVG-stained sections and positively stained areas of Mϕ and SMC were quantified with an image analysis system 
(bottom panel). Values are mean ± SEM, n = 6-7. *P < .05 vs non-Tg rabbits
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by Western blotting and zymography (Figure 7A). Low expression 
of MMP-9 in the lesions of hypercholesterolemic rabbits was also 
reported in the previous study.45 High levels of MMP-9 expres-
sion of the lesions in Tg rabbits were associated with incremental 
gelatin-degrading activity as shown by gel zymographic analysis, in situ 
zymography, and gelatinase activity assay (Figure 7B,C). Gelatinase 
activity in aortic lesions visualized by in situ zymography can be in-
hibited in the presence of EDTA (data not shown). Furthermore, we 
F I G U R E  3   Comparison of histological features of advanced atherosclerotic lesions of aorta. Male Tg and non-Tg rabbits were fed a 
cholesterol diet for 28 weeks, and the aortic lesions were then quantified microscopically. Representative micrographs of the aortic arch 
lesions are shown on the top panel. Serial paraffin sections of the aortic arch were stained with haematoxylin and eosin (HE) and von Kossa 
or immunohistochemically stained with monoclonal antibodies (mAbs) against either macrophages (Mϕ) or α-smooth muscle actin for smooth 
muscle cells (SMC). Intimal lesions on EVG-stained sections and positively stained areas of Mϕ and SMC in the intima were quantified with 
an image analysis system (bottom panel). Advanced lesions were measured by calculating the average length of lesions with lipid cores and 
calcification as described in the Methods. Values are mean ± SEM, n = 10-12. *P < .05, **P < .01 vs non-Tg rabbits
F I G U R E  4   MMP-9 expression increases aortic calcification in Tg rabbits. The aortic arch sections (8-10 sections for each animal) were 
stained with von Kossa stain (A), and both the calcified area and length on the sections were measured. Values are mean ± SEM, n = 10-16. 
Each dot represents the data of an individual animal. *P < .05, **P < .01 vs non-Tg rabbits
     |  4269CHEN Et al.
found that carrageenan-induced granulomas of Tg rabbits contained 
significantly less extracellular matrix content (47% decrease, P < .01) 
than those of non-Tg rabbits (Figure 7D). In addition, Western blot-
ting showed that increased MMP-9 was actually accompanied by 
significant increase of MMP-2, MMP-12, TIMP-1 and TIMP-2 in Tg 
rabbits (Figure 7E).
3.5 | MMP-9 enhances macrophage migration and 
digestion of extracellular matrix
To clarify the mechanisms responsible for increased macrophage ac-
cumulation in the lesions of Tg rabbits, we compared the capacity 
of alveolar macrophages isolated from Tg and non-Tg rabbits to in-
vade an immobilized ECM in vitro. In response to the presence of the 
chemoattractant MCP-1, the number of gel-invading macrophages 
from Tg rabbits was 2.3-fold greater than that from non-Tg rabbits 
(P < .01) (Figure 7F).
4  | DISCUSSION
Accumulation of macrophage-derived foam cells in the intima of 
large arteries is a hallmark of atherosclerosis. Macrophages secrete 
a variety of bioactive substances, such as MMPs and cytokines, 
thereby playing an important role in lesion formation and progres-
sion.32 In the current study, we focused on MMP-9, an important 
gelatinase, and generated Tg rabbits that overexpressed MMP-9 in 
the macrophage lineage to examine whether increased MMP-9 ex-
pression affects the initiation and progression of atherosclerosis. For 
this undertaking, we fed Tg and non-Tg rabbits a cholesterol diet for 
16 and 28 weeks.
In the first experiment, we did not see any significant influence 
of MMP-9 expression on the fatty streak size but the macrophage 
number was indeed increased in the lesions of Tg rabbits. In this as-
pect, MMP-9 is similar to other MMPs such as MMP-1 (collagenase) 
and MMP-12 (elastase) because Tg rabbits expressing either MMP-
123 or MMP-1247 in macrophages also failed to increase the fatty 
F I G U R E  5   Different microscopic patterns of aortic calcification in Tg rabbits. Calcified materials were observed in the centre of fatty 
streak type lesions (possibly associated with apoptotic macrophages) (the arrows point the calcified area) (A). Calcification was associated 
with fragile or unstable lesions which have a large lipid core and a thin cap (B). (Note: the surface of the lesions looks ‘erupted’ possibly 
caused by artefact during the specimen preparation). Calcium particles (~1 μm) within macrophage accumulation are possibly those of so-
called microcalcification-generating matrix vesicles (von Kossa staining on the right) (C)
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F I G U R E  6   MMP-9 expression increases coronary calcification in Tg rabbits after feeding a cholesterol diet for 28 weeks. Serial paraffin 
sections of left coronary artery lesions of male non-Tg and Tg rabbits were stained with H&E, mAb against macrophages or von Kossa. 
The coronary stenosis = lesion area/total lumen area × 100(%) was measured and is expressed as a percentage, and the macrophages (Mϕ) 
positive area and calcification area in lesions were quantified. Data are expressed as mean ± SEM, n = 8 for each group. Each dot represents 
the data of an individual animal. *P < .05, **P < .01 vs non-Tg rabbits
F I G U R E  7   Demonstration of increased MMP-9 expression in the lesions of Tg rabbits. Proteins isolated from aortic samples were 
fractionated on 10% SDS-PAGE and immunoblotted with MMP-9 and β-actin was used as an internal control (A, top). Zymography was 
performed using gelatin as substrate as described in the Methods (A, bottom). n = 3 for each group. To measure the gelatinase enzymatic 
activity directly in the lesions, we performed in situ zymography as described in the Methods. The gelatinase activity on the sections 
of aortic lesions was visualized as green, and nuclei were stained as blue (B). White dotted lines indicate the internal elastic lamina. 
For quantification of gelatinase activity, the homogenate of aortic arch was mixed with quenched fluorescein-conjugated gelatin, and 
fluorescent density was measured and expressed as the gelatinase activity (C). High gelatinase activity of Tg rabbits was inhibited in the 
presence of MMP-2/9 inhibitors (C). Values are mean ± SEM, n = 4 for each group. Carrageenan-induced granuloma sections were prepared 
as described in the Methods (D). Paraffin sections of granulomas were stained by Masson trichrome staining, and the positive areas for 
collagen fibres (blue or purple) were quantified with an image system (D). Ten high-power fields (HPF) of each section were randomly 
selected and calculated. Data are expressed as mean ± SEM, n = 4 for each group. **P < .01 vs non-Tg rabbits. Proteins isolated from aortic 
arch were fractionated on 10% SDS-PAGE and immunoblotted with each mAb against MMP-2, MMP-12, TIMP-1 TIMP-2 and β-actin (E). 
Data are expressed as mean ± SEM and n = 4 for each group. Alveolar macrophage chemotaxis assays were performed as described in the 
Methods. Results are expressed as the average number of cells that migrated through immobilized ECM film after 48 h incubation (F). Data 
are expressed as mean ± SEM and n = 4 for each group. **P < .01 vs non-Tg rabbits
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steak formation. Meanwhile, macrophage lineage overexpressing 
MMP-9 in apoE KO mice showed no effects on lesion size.41 It has 
been reported that MMP-9 deficiency appears to enhance plaque 
growth in apoE/MMP-9 double KO mice30 although MMP-9 defi-
ciency protected against cholesterol diet-induced atherosclerosis in 
the same double KO mice.29
In the second experiment, rabbits were fed a cholesterol diet for 
28 weeks and developed greater and more advanced lesions (than 
experiment one) which enabled us to examine whether increased 
MMP-9 affects the progression of atherosclerosis. Although the 
aortic arch lesions stained by Sudan IV became almost saturated 
at 28 weeks, gross lesion areas were significantly increased in fe-
male (not male) Tg rabbits. The molecular mechanism for this gen-
der effect of MMP-9 is still unknown but it will be interesting to 
investigate whether sex hormones interact with MMP-9 in future. 
Nevertheless, lesional macrophages were significantly increased in 
both aortic and coronary atherosclerotic lesions in both male and 
female Tg rabbits compared with non-Tg rabbits. Accumulation of 
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macrophages in the lesions even extended to the deeper medial 
tunica or even the adventitia. Although it is still unknown whether 
these adventitial macrophages come from the inside or outside, it is 
most likely that they develop as a result of ‘outside in’ rather than 
‘inside out’ migration. Regardless of this assumption, emigration of 
monocytes/macrophages requires the degradation of the ECM and 
increased MMP-9 activity in Tg macrophages undoubtedly leads to 
enhancement of ECM degradation thereby facilitating the influx 
of monocyte/macrophages into the lesions.28 This contention was 
further supported by our chemotaxis study and granuloma model 
assay showing that macrophages from Tg rabbits exhibited higher 
infiltrative activity towards a chemoattractant, MCP-1 in vitro and 
augmented capability of hydrolysing ECM in granulomatous tissue 
(Figure 7). Previous studies using apoE KO mice demonstrated that 
local expression of catalytic form of MMP-9 by adenoviral vectors 
enhances plaque rupture and haemorrhage.16,48 In the current study, 
we observed so-called “vulnerable sites” in the aortic lesions of Tg 
rabbits but did not find any plaque ruptures, suggesting pro-MMP-9 
activation is a key process of MMP-9-derived plaque rupture.
In spite of this, one of the most striking findings observed in the 
current study was the demonstration of remarkable calcification 
in the aortic and coronary lesions in Tg rabbits, which mimicked 
human advanced atherosclerotic lesions with calcification.17,49 
This finding was initially unexpected and surprising, but it is pos-
sible that MMP-9 may mediate vascular calcification through 
several possible molecular mechanisms.50,51 First, it has been 
reported that apoptotic macrophages in the lesions can release 
microcalcification-generating matrix vesicles into the ECM, even-
tually resulting in calcification52 which is supported by our finding 
that macrophage-rich lesions contained microcalcification. High 
expression of caspase-3 in the lesions of Tg rabbits allowed us 
to speculate that increased cell death may be also involved in the 
process of vascular calcification. Given the fact that overexpres-
sion of MMP-9 led to the incremental infiltration of macrophages 
in the lesions of Tg rabbits, it is presumable that apoptotic mac-
rophages would be increased. It is not clear; however, whether 
increased MMP-9 expression changes the calcium milieus in the 
intima, or stimulates macrophages to release more microcalcifi-
cation-generating matrix vesicles.53 Second, it is well known that 
macrophages can differentiate into osteoclasts that help the ac-
tive resorption of the ECM in the arterial wall. If this process was 
retarded, calcium deposition in the lesions would be enhanced. 
This notion was supported by the observation that TRAP stain-
ing, a histochemical marker for osteoclast differentiation54 were 
significantly reduced in atherosclerotic lesions of Tg rabbits com-
pared with non-Tg rabbits (Figure S10). Finally, besides macro-
phages, vascular smooth muscle cells constitute another cellular 
source that participates in the vascular calcification. For example, 
increased MMP-9 can lead to incremental hydrolysis of elastin 
and such soluble elastin-derived peptides from MMP-9 hydroly-
sis promote osteogenic differentiation of SMCs in arterial wall.55 
In addition to MMP-9, the lesional MMP-2 expression was simul-
taneously increased in Tg rabbits possibly caused by increased 
macrophages in the lesions, which may also affect lesion devel-
opment and vascular calcification.56,57 It should be pointed out 
that in addition to MMPs, cathepsins or other proteinases in the 
lesions may be also involved in the lesion development.58,59 It will 
be interesting to investigate how these proteinases play an inter-
active role in the development of atherosclerosis. Nevertheless, 
vascular calcification in the atherosclerotic lesions apparently af-
fects arterial stiffness and contractility thus impairing blood flow 
which leads to ischaemia in the organs. Our current results may 
support the notion that inhibition of vascular macrophage-de-
rived MMP-9 may become a new potential therapeutics to pre-
vent vascular calcification,60,61 while this hypothesis remains to 
be verified in future.
In conclusion, we have successfully created Tg rabbits that 
overexpress MMP-9 specifically in macrophage lineage. Increased 
expression of MMP-9 in macrophages not only enhances the forma-
tion of advanced atherosclerotic lesions in Tg rabbits, but also leads 
to a marked vascular calcification. Therefore, macrophage-derived 
MMP-9 in the arterial wall may exert other physiological functions 
beyond its classical gelatinase activity. Although the molecular 
mechanisms remain yet to be clarified, it will be interesting to in-
vestigate in the future whether inhibition of MMP-9 functions as a 
therapeutic method to inhibit vascular calcification.
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